Literature DB >> 8343321

A comparison of transoesophageal atrial pacing and direct current cardioversion for the termination of atrial flutter: a prospective, randomised clinical trial.

K J Tucker1, C Wilson.   

Abstract

OBJECTIVE: To compare the safety and efficacy of transoesophageal atrial pacing (TAP) with an easily swallowed pill electrode and direct current cardioversion (DCC) in patients with atrial flutter that was refractory to appropriate medical treatment.
DESIGN: Prospective, randomised clinical trial.
SETTING: Community based United States naval hospital.
SUBJECTS: Twenty one consecutive patients with refractory atrial flutter selected consecutively from the inpatient cardiology consultation service. All patients were haemodynamically stable and medical treatment with a class IA or IC antiarrhythmic agent had failed. Eleven patients were treated with TAP and 10 patients were treated with DCC.
INTERVENTIONS: Digoxin was given to all patients to control the ventricular rate to < 100/minute. MAIN OUTCOME MEASURE: Conversion to normal sinus rhythm and arrhythmias after cardioversion.
RESULTS: Conversion to normal sinus rhythm was similar in both groups (TAP 8/11, DCC 9/10, p = 0.31). Arrhythmias after cardioversion including third degree heart block and non-sustained ventricular tachycardia were more frequent in the DCC group (TAP 0/11, DCC 6/10, p = 0.02).
CONCLUSION: Transoesophageal atrial pacing with an easily swallowed pill electrode is safe, well tolerated, and is as efficacious as DCC for refractory atrial flutter.

Entities:  

Mesh:

Year:  1993        PMID: 8343321      PMCID: PMC1025166          DOI: 10.1136/hrt.69.6.530

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  19 in total

1.  VENTRICULAR TACHYCARDIA AFTER SYNCHRONIZED DIRECT-CURRENT COUNTERSHOCK.

Authors:  W S GRAF; P ETKINS
Journal:  JAMA       Date:  1964-11-02       Impact factor: 56.272

2.  Resuscitation of the heart in ventricular standstill by external electric stimulation.

Authors:  P M ZOLL
Journal:  N Engl J Med       Date:  1952-11-13       Impact factor: 91.245

3.  Use of the pill electrode for transesophageal atrial pacing.

Authors:  J M Jenkins; M Dick; S Collins; W O'Neill; R M Campbell; D J Wilber
Journal:  Pacing Clin Electrophysiol       Date:  1985-07       Impact factor: 1.976

4.  Direct current shock and digitalis. A clinical and experimental study.

Authors:  P Szekely; N A Wynne; D T Pearson; G A Batson; D A Sideris
Journal:  Br Heart J       Date:  1969-01

5.  Transesophageal atrial pacing using a pill electrode for the termination of atrial flutter.

Authors:  R H Falk; M Werner
Journal:  Chest       Date:  1987-07       Impact factor: 9.410

6.  Continuous rapid atrial pacing to control recurrent or sustained supraventricular tachycardias following open heart surgery.

Authors:  A L Waldo; W A MacLean; R B Karp; N T Kouchoukos; T N James
Journal:  Circulation       Date:  1976-08       Impact factor: 29.690

7.  Cardioversion and digitalis. II. Clinical studies.

Authors:  R Kleiger; B Lown
Journal:  Circulation       Date:  1966-06       Impact factor: 29.690

8.  Disopyramide: serum level and arrhythmia conversion.

Authors:  A P Niarchos
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

9.  Prospective evaluation of transesophageal pacing for the interruption of atrial flutter.

Authors:  W Crawford; V J Plumb; A E Epstein; G N Kay
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

10.  Facilitating influence of disopyramide on atrial flutter termination by overdrive pacing.

Authors:  P Della Bella; C Tondo; G Marenzi; C M Cipolla; F Doni; S Grazi; A Rimondini; A Salvioni; M D Guazzi
Journal:  Am J Cardiol       Date:  1988-05-01       Impact factor: 2.778

View more
  1 in total

1.  Transesophageal echocardiography of intracardiac thrombus in congenital heart disease and atrial flutter: the importance of thorough examination of the Fontan.

Authors:  Nida Yousef; Molly Philips; Ira Shetty; Vivian Wei Cui; Frank Zimmerman; David A Roberson
Journal:  Pediatr Cardiol       Date:  2014-04-20       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.